RxSight (RXST) Gross Margin (2020 - 2026)
RxSight's (RXST) quarterly Gross Margin came in at 76.06% in Q1 2026, up 131.0% on a YoY basis from 32.93% in Q1 2025, and down 1.82% quarter-over-quarter from 77.47% in Q4 2025.
Powered by 
Analysis
RxSight (RXST) Gross Margin (2020 - 2026) Analysis & Trends
RxSight (RXST) has reported Gross Margin for 7 consecutive years, with 76.06% the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 131.0% year-over-year to 76.06%; the trailing twelve-month figure through Mar 2026 stood at 77.02% (up 515.0% YoY), and the FY2025 full-year result was 76.6%, up 589.0% from the prior year.
- Gross Margin eased to 76.06% in Q1 2026 per RXST's latest filing, from 77.47% in the prior quarter.
- Across five years, Gross Margin topped out at 79.85% in Q3 2025 and bottomed at 42.06% in Q1 2022.
- Historically, Gross Margin has averaged 63.47% across 5 years, with a median of 69.51% in 2024.
- The sharpest annual moves came in 2022 and 2026: Gross Margin surged 5873 bps in 2022, then soared 131 bps in 2026.
- Over 5 years, Gross Margin stood at 46.13% in 2022, then soared by 34 bps to 61.77% in 2023, then grew by 16 bps to 71.59% in 2024, then grew by 8 bps to 77.47% in 2025, then fell by 2 bps to 76.06% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 76.06%, 77.47%, and 79.85% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 76.06% |
| Dec 31, 2025 | 77.47% |
| Sep 30, 2025 | 79.85% |
| Jun 30, 2025 | 74.89% |
| Mar 31, 2025 | 74.76% |
| Dec 31, 2024 | 71.59% |
| Sep 30, 2024 | 71.42% |
| Jun 30, 2024 | 69.51% |
| Mar 31, 2024 | 70.09% |
| Dec 31, 2023 | 61.77% |
| Sep 30, 2023 | 61.85% |
| Jun 30, 2023 | 57.74% |
| Mar 31, 2023 | 59.27% |
| Dec 31, 2022 | 46.13% |
| Sep 30, 2022 | 42.46% |
| Jun 30, 2022 | 42.15% |
| Mar 31, 2022 | 42.06% |
| Dec 31, 2021 | 34.05% |
| Sep 30, 2021 | 23.18% |
| Jun 30, 2021 | -16.58% |